logo

ENSC

Ensysce Biosciences·NASDAQ
--
--(--)
--
--(--)

ENSC fundamentals

Ensysce Biosciences (ENSC) released its earnings on Aug 13, 2025: revenue was 1.37M (YoY +653.59%), beat estimates; EPS was -0.79 (YoY -259.09%), beat estimates.
Revenue / YoY
1.37M
+653.59%
EPS / YoY
-0.79
-259.09%
Report date
Aug 13, 2025
EPS
Revenue

Revenue & Expenses

ENSC has released its 2025 Q3 earnings report, with revenue of 493.10K, reflecting a YoY change of -85.58%, and net profit of -3.73M, showing a YoY change of -663.51%. The Sankey diagram below clearly presents ENSC's revenue sources and cost distribution.

Key Indicators

Ensysce Biosciences (ENSC) key financial stats and ratios, covering profitability, financial health, and leverage.
Ensysce Biosciences (ENSC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Ensysce Biosciences (ENSC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Ensysce Biosciences (ENSC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Ensysce Biosciences (ENSC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Ensysce Biosciences (ENSC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield